Table 2.
Patient characteristics
| Characteristics | First perioda | Second periodb | p value |
|---|---|---|---|
| No. of patientsc | 277 | 274 | |
| Age [years; mean (SD)] | 63 (11.6) | 66 (24.8) | 0.24 |
| Male [n (%)] | 178 (64) | 173 (63) | 0.49 |
| Second opinion | 39 (14) | 64 (23) | 0.87 |
| Diagnosis at first MDTM [n (%)] | 0.39 | ||
| Correct diagnosis | 238 (86) | 240 (88) | |
| Incorrect diagnosis | 8 (3) | 10 (4) | |
| Treatment intent [n (%)] | 0.26 | ||
| Curative | 105 (38) | 123 (45) | |
| Palliative | 78 (28) | 78 (29) | |
| Unknown | 72 (26) | 56 (20) | |
| Not applicable | 22 (8) | 17 (6) | |
| Tumor-specific MDT [n (%)] | |||
| HCC | 31 (11) | 19 (7) | 0.046 |
| CRC | 56 (20) | 56 (20) | 0.95 |
| ESOGAS | 74 (27) | 87 (32) | 0.19 |
| PB | 116 (42) | 112 (41) | 0.81 |
| Time/MDTM [hours; mean (SD)] | |||
| HCC | 45:54 (16) | 39:16 (7) | 0.007 |
| CRC | 50:32 (12) | 53:44 (17) | 0.43 |
| ESOGAS | 63:00 (11) | 62:00 (11) | 0.13 |
| PB | 71:00 (7) | 73:00 (9) | 0.18 |
| Time/patient [min; mean (SD)] | |||
| HCC | 06:28 (2) | 07:23 (3) | 0.34 |
| CRC | 05:34 (2) | 06:09 (3) | 0.30 |
| ESOGAS | 05:32 (2) | 05:09 (3) | 0.40 |
| PB | 04:27 (1) | 04:59 (2) | 0.056 |
p values were calculated using a Chi square test
aFirst period: 27 December 2012 to 12 March 2013
bSecond period: 24 September 2013 to 5 December 2013
cOnly individual patients were considered in this table
HCC hepatocellular carcinoma, CRC colorectal carcinoma, ESOGAS esophageal and gastric cancer, PB pancreatic and biliary tumors, SD standard deviation, MDT multidisciplinary team, MDTM multidisciplinary team meeting